Valuation : DBV Technologies

Market Cap 682M 792M 642M 586M 1.1B 74.88B 1.1B 7.58B 2.94B 38.39B 2.98B 2.91B 124B P/E 2026 *
-5.24x
P/E 2027 * -16.1x
Enterprise Value 607M 705M 571M 521M 975M 66.6B 978M 6.74B 2.62B 34.15B 2.65B 2.59B 110B EV / Sales 2026 *
237x
EV / Sales 2027 * 9.39x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-4.24%
Current month+0.35%
1 month+1.95%
3 months-21.88%
6 months-37.59%
Current year-29.05%
1 week 2.23
Extreme 2.234
2.32
1 month 2.23
Extreme 2.234
2.51
Current year 2.23
Extreme 2.234
4.14
1 year 1.41
Extreme 1.412
4.75
3 years 0.44
Extreme 0.4355
4.75
5 years 0.44
Extreme 0.4355
9.73
10 years 0.44
Extreme 0.4355
84.99
Manager TitleAgeSince
Chief Executive Officer 66 2018-11-28
Director of Finance/CFO 56 2023-11-05
Chief Operating Officer - 2023-11-30
Director TitleAgeSince
Director/Board Member 51 2015-10-20
Director/Board Member 63 2016-06-20
Director/Board Member 60 2017-06-14
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-4.24% - - 793M
-1.32%+1.33%+78.86%+36.86% 371B
-1.45%-3.14%+25.21%-19.54% 68.64B
-0.51%+4.59%+50.12%+157.33% 12.51B
-1.09%-9.76%-8.91%-9.69% 8.06B
+0.23%-1.59%-19.07%+5.74% 5.04B
0.00%-4.12%-31.08%+21.23% 4.51B
-0.35%-3.11%-31.69%+0.12% 3.07B
-1.00%-0.46%-4.18%+33.98% 2.53B
-0.50%-3.98%-23.45%-18.72% 2B
Average -0.58%-1.80%+3.98%+23.04% 53.03B
Weighted average by Cap. -1.27%+0.87%+65.25%+30.16%

Financials

2026 *2027 *
Net sales 2.56M 2.97M 2.41M 2.2M 4.12M 281M 4.13M 28.46M 11.05M 144M 11.17M 10.92M 465M 70.24M 81.56M 66.03M 60.32M 113M 7.71B 113M 780M 303M 3.95B 306M 300M 12.75B
Net income -174M -202M -164M -149M -280M -19.1B -281M -1.93B -751M -9.79B -759M -742M -31.59B -116M -135M -109M -99.61M -186M -12.73B -187M -1.29B -500M -6.53B -506M -495M -21.05B
Net Debt -75.46M -87.62M -70.94M -64.8M -121M -8.28B -122M -838M -326M -4.25B -329M -322M -13.69B -22.7M -26.36M -21.34M -19.49M -36.48M -2.49B -36.6M -252M -97.92M -1.28B -98.98M -96.81M -4.12B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change
26-09-04 €2.306 +0.17%
26-09-03 €2.302 +3.04%
26-09-02 €2.234 -3.54%
26-09-01 €2.316 +0.78%
26-08-31 €2.298 -4.57%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.306EUR
Average target price
3.637EUR
Spread / Average Target
+57.70%

Quarterly revenue - Rate of surprise